7 results
DEFM14A
RVMD
Revolution Medicines Inc
29 Sep 23
Proxy related to merger
4:19pm
and reviewed an illustrative process timeline.
On June 13, 2023, the EQRx compensation and talent development committee held a meeting at which Mr … discussions regarding a potential transaction with Revolution Medicines at the meeting). The EQRx compensation and talent development committee requested
424B3
RVMD
Revolution Medicines Inc
29 Sep 23
Prospectus supplement
4:17pm
, 2023, the EQRx compensation and talent development committee held a meeting at which Mr. Borisy, other members of senior management of EQRx … Medicines at the meeting). The EQRx compensation and talent development committee requested that management prepare a specific proposal of retention
S-4/A
RVMD
Revolution Medicines Inc
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm
.
On June 13, 2023, the EQRx compensation and talent development committee held a meeting at which Mr. Borisy, other members of senior management of EQRx … with Revolution Medicines at the meeting). The EQRx compensation and talent development committee requested that management prepare a specific proposal
S-4
RVMD
Revolution Medicines Inc
13 Sep 23
Registration of securities issued in business combination transactions
5:20pm
an illustrative process timeline.
On June 13, 2023, the EQRx compensation and talent development committee held a meeting at which Mr. Borisy, other members … a potential transaction with Revolution Medicines at the meeting). The EQRx compensation and talent development committee requested that management prepare
- Prev
- 1
- Next